Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_538_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
86 Мб
Скачать
242
Fig. 12.9 Diamond (rhomboid) ap
V. L. Tsikitis and S. Marecik
Fig. 12.10 House ap
ap into the anal canal. Clinical improvement or healing of the stenosis was reported in more than 90% of patients (Fig.12.10) [8385].
U Flap (Island Flap Anoplasty)
This technique was developed by Pearl etal. and can also be used in the treatment of ectropion as well as distal stula in ano [86]. The U ap provides a wide-base island ap that can cover a large area of anodermal defect, similar to the previ­ously described techniques. The important difference, how­ever, is that the donor site in this technique is not closed but is left open for secondary healing. Initially, wet to dry gauze application is required to allow the area to granulate. Dry gauze can then be used to allow the wound to epithelialize. Of 25 patients treated with this aps (20 for anal stenosis and 5 for mucosal ectropion), 16 reported excellent and 7 reported good results [86].
Rotational S Flap
This technique is used most often to cover larger defects resulting from the excision of perianal Paget’s or Bowen’s disease. The rotational S flap (S-plasty) can also be used to effectively move a significant amount of perianal skin into the anus in order to cover a large defect after circumferential excision of the stenotic scar in the
distal anal canal. In this technique, two full-thickness, well-vascularized cutaneous flaps with an appropriate amount of underlying subcutaneous tissue (sometimes as fascio-cutaneous flaps) are created by the S-shape inci­sion and centered around the anal opening. The flaps are subsequently advanced, rotated into the distal anus along the incision, and sutured to the non- strictured rec­tal mucosa, as well as to the corresponding edges of the defect (Fig.12.11) [87, 88].
Technical Aspects
Reconstructive ap procedures are performed after mechani­cal bowel preparation. A complete bowel preparation may be difcult to accomplish in patients with anal stenosis. Frequently, a prolonged 1–2-day bowel preparation is required in addition to a roughage-free diet for several days prior to the procedure. If the patient is found to have a large amount of liquid stool in the colon immediately before the procedure, an ad hoc colonoscopic washout and aspiration can be performed.
The mechanical bowel preparation can be supplemented with oral antibiotic administration. This is in line with cur­rent recommendations for proctectomy cases, since the anas-
Defect
ab
cd
Stricture excision
12 Anal Fissure andAnal Stenosis
243
Mucosa
Fig. 12.11 Rotational ap (a) scar excision, (b) internal sphincterotomy, (c) ap creation, (d) ap xation in place
tomosis (suture line) is created in the ap cases. Perioperative antibiotics are given. In cases with large amount of contami­nation, a low-concentration chlorhexidine solution jet irriga­tion can be used (Irrisept®). The choice of post procedure antibiotics (IV, oral, or none) is dependent upon the com­plexity of the case, bowel preparation, and surgeon preference.
Most of the ap procedures are performed with the patient in the prone jackknife position, with the exception of poste­rior rectal advancement aps. The buttocks are initially taped
apart and the Lone-Star retractor can be useful. Low wattage cautery and sharp knife dissection are used.
In the current era of effective hemostasis, hemostatic epi­nephrine solution injection is primarily reserved for cases of stubborn bleeding from the scar tissue. Alternatively, epinephrine- soaked gauze application can be utilized. Additionally, injection of epinephrine into the ap can lead to ischemia of its terminal parts, whereas injection into the dissected tissues can disturb the surgical planes or even decrease the effective space in an already tight anal canal.
244
V. L. Tsikitis and S. Marecik
Excision of the scar requires precision and should avoid thermal injury to the underlying healthy tissues. Frequently a thin layer of the scar can be inltrated with saline or epineph­rine solution and removed sharply.
It is important that the minimal amount of absorbable suture material is used, typically 2-0 Vicryl for strength and 3-0 Vicryl or Chromic for tissue approximation. Occasionally, a few non­absorbable strength sutures can be placed. Care should be taken to avoid dead space formation underneath the aps.
In selected cases, the ap reconstruction can be protected using a diverting ostomy, most often created with laparo­scopic assistance at the end of the procedure. Tenuous repairs with poor bowel preparation and negative predictive healing factors can be the determinants for prophylactic diversion.
Flap Aftercare
The majority of ap procedures are performed on an outpa­tient basis. Patients are instructed to not sit directly on the repair site. Showering or rinsing with water is recommended, particularly when soiling with stool occurs. The wounds should then be covered with dry dressings to prevent tissue maceration. Wet to dry dressings are suggested for the open wounds.
Close follow-up is necessary to observe for any ap isch­emia, suture line breakdown, granulomas, or wound dehis­cence. Localized dehiscence is not uncommon but can be effectively monitored and treated in the ofce setting and by thorough wound care. Not healed wound dehiscence can lead to chronic ssures, especially when associated with ap ischemia. Patients should be seen in the ofce within 5days from surgery in order to check on wound healing and to rein­force the aftercare instructions.
Postoperative bowel rest can be benecial and is fre­quently used by surgeons for complex and repeat repairs. Pharmacological bowel rest with antimotility and narcotic agents can be used; however, the consequences of subse­quent stool buildup, fecal impaction, and its effect on the healing wound should be carefully weighed. Today, an avail­able option is total or peripheral parenteral nutrition (TPN or PPN), which can often be administered in the home setting via the PICC line or Medline®, respectively. This route of nutrition can be effectively combined with a liquid diet high in fat and protein to provide sufcient nutrition during the rst 1–2weeks of healing. The cost of this approach is more favorable compared to the option of protective diverting ostomy (author’s observation).
Alternatively, patients can be restarted on a soft high-ber diet with an appropriate amount of water to bulk up the stools and prevent constipation (similar to the bowel regimen for the ssure patients). Local antibiotic ointments (e.g., triple antibiotic ointment) can be used for topical application.
Postoperative pain control can be provided by intraopera­tive injection of liposomal bupivacaine (e.g., Exparel®) as well as oral analgesia (e.g., nonsteroidal anti-inammatory drugs (NSAIDs), acetaminophen, Lyrica®). Stool softeners are recommended during opioid analgesia. Diarrhea should be prevented, since liquid stool appears to be more detrimen­tal to ap repairs than bulky or rm stool.
A successful ap procedure rarely requires further dila­tion maneuvers. However, if recurrent stricture formation is identied, dilations should be performed.
Choosing theRight Procedure
The ideal procedure should be simple, effective, and free from serious morbidity and should restore the anal function for a good long-term outcome. Unfortunately, there is no one-ts-all solution. The choice of procedure should also depend on the surgeon’s comfort level. The involvement of the scar tissue needs to be determined. Repair of the stenosed anoderm will fail if the concomitant internal sphincter bro­sis is not addressed. Conversely, the lateral internal sphinc­terotomy will not be successful if the problem of the concomitant anodermal stenosis is not corrected [63].
Not every stenosis needs correction. Patients with asymp­tomatic stenosis found during digital rectal exam should only be instructed about dietary modications and the potential need for dilations should symptoms occur. The possibility of underlying malignancy must also be excluded.
The simplest form of anoplasty involves longitudinal inci­sion of the involved tissue with transverse closure of the resulting diamond-shape defect in a Heineke-Mikulicz fashion. This approach can be utilized for stenosis at differ­ent levels in the anal canal and performed more than once around the circumference. It is reserved for small areas of stenosis, has a high chance for restenosis, and may require additional dilations [69]. For proximal and mid-anal steno­sis, rectal advancement aps should be considered.
Mid and distal anastomosis can be successfully treated with Y-V aps; however, the tip of the ap can be at risk for ischemia if signicant tension is applied. If the Y-V ap can­not reach into the desired location without excessive tension; it can be converted into the diamond island ap [69]. Insufcient release of the stenosis with one diamond ap can be addressed by a repeated procedure on the contralateral site.
For scenarios that require advancement of a larger amount of tissue in both transverse and longitudinal aspects, the V-Y, house, and U ap (island ap anoplasty) are more appropri­ate. They can also be performed bilaterally. Circumferential excision of the distal anoderm is best addressed by the rota­tional S-plasty or larger skin aps, based on the named vas­cular pedicles [79, 8789].
12 Anal Fissure andAnal Stenosis
245
It is extremely difcult to comparatively interpret the results of many case series involving various reconstructive procedures. The only randomized study by Farid compared the house ap, rhomboid ap, and Y-V anoplasty in anal ste­nosis patients. The average operative times were the longest in the house ap group (62min) and the shortest in the Y-V anoplasty (35min). The anal caliber at 1year was the largest in the house ap group, together with the highest quality of life score and a signicant improvement of symptoms (p < 0.05) [83]. Helpful summaries of the ap procedures with their respected outcomes have been presented by Brisinda and Shawki [48, 54].
Few complications have been reported with most of these techniques. They can include infection, ap failure, recur­rence of the stenosis, fecal incontinence, and impaction [54]. In cases where no satisfactory results can be obtained using the abovementioned procedures, a diverting colostomy remains the last resort option.
Anal Stenosis inCrohn’s Disease
Anal stenosis in Crohn’s disease is common and does not frequently manifest itself clinically due to the liquid nature of stools in this patient population. The stricturing, stuliz­ing, and ssuring nature of the disease, with subsequent healing attempts, can lead to the possibility of anal stenosis at any level of the anal canal and frequently involves the ano­rectal junction. Poor wound healing, constant inammation, and scar tissue formation pose a signicant challenge for the possibility of surgical correction.
In a study of 224 patients with anorectal complications of Crohn’s disease, 65 patients presented with anal steno­sis, and 4 patients went on to develop anal stenosis during the study [67]. Most of these patients specically indicated that anal stenosis was their only complaint, and only a small number of patients from this group required abso­lutely no surgical intervention. Another 16 patients under­went mechanical dilatation, and 17 patients ultimately underwent proctectomy or diverting stoma within a mean follow-up of 19 months. In another study of 44 patients with anal stenosis secondary to Crohn’s disease, 75% underwent mechanical dilatation and 43% eventually required proctectomy [66]. Brochard reported successful healing in Crohn’s-related anorectal stricture in 59% over the course of 8.9years [90].
These results highlight the signicant risk of loss of bowel continence in patients with Crohn’s disease and anal steno­sis. Some authors have suggested that manual anal dilatation may result in further scarring and progressive stenosis or incontinence and should thus be avoided in patients with Crohn’s disease [51, 61, 68].
Prevention
Avoidance of several crucial mistakes during hemorrhoidec­tomy, which is the procedure responsible for 90% of all ste­nosis cases, should decrease the chance of this complication occurring. In particular, overzealous removal of all abnormal hemorrhoidal tissue should be avoided, and the mucocutane­ous bridges of viable tissue should be preserved (>1 cm strips). Some of the remaining abnormal hemorrhoidal tissue can be incorporated into the closure suture line, thus elimi­nating the need to remove it altogether.
Other devascularization techniques (suture ligation, sup­plemental rubber band ligation) can also be used to address the remaining engorged hemorrhoidal tissue. Three-quadrant hemorrhoidectomy can often be replaced by two-quadrant excision, with the addition of limited resection or rubber band­ing of the third remaining hemorrhoidal pedicle. Often, the remaining smallest third pedicle is so devascularized after the two other columns are removed that no resection is needed. Techniques of vascular plexus resection with preservation of the anoderm or hemorrhoidopexy can also be utilized.
Finally, treatment of acute grade IV hemorrhoidal disease should be done with caution, since the majority of the ano­derm is abnormally swollen at the time of the resection and will return to normal after the acute process is resolved. Injection of a local anesthetic before the resection of the hemorrhoid or a skin tag articially “inates” the tissues. In the end, this can result in excessive resection. In many cases, the rectal mucosa can be anchored to the internal sphincter at the level of the dentate line, or even more distally, thereby avoiding the need to close each wound in the vertical fash­ion. Similarly, some of the remaining anoderm of the anal verge can be anchored into the sphincter in order to prevent its outward retraction.
Resection of the hemorrhoidal tissue in the anterior or posterior midline can lead to poor wound healing, ssure for­mation, and anal stenosis and thus should be avoided if pos­sible. Care should be taken to minimize the thermal injury to the non-resected tissues in the anal canal.
Anal Stenosis, Conclusions
Anal stenosis is a rare but serious problem, which every colorectal surgeon will encounter. Prevention of this compli­cation is crucial among any surgeon who is addressing the anorectal pathology. Appropriately performed hemorrhoid­ectomy should minimize the risk of anal stenosis. Conservative management is reserved for mild stenosis cases. Several surgical options for moderate and severe ste­nosis include sphincterotomy, stricturotomy or stricturec­tomy, and appropriate ap anoplasty.
246
V. L. Tsikitis and S. Marecik

References

1. Keck JO, Staniunas RJ, Coller JA, Barrett RC, Oster ME.Computer­generated proles of the anal canal in patients with anal ssure. Dis Colon Rectum. 1995;38(1):72–9.
2. Hananel N, Gordon PH. Re-examination of clinical manifesta­tions and response to therapy of ssure-in-ano. Dis Colon Rectum. 1997;40(2):229–33.
3. Poh A, Tan KY, Seow-Choen F.Innovations in chronic anal s­sure treatment: a systematic review. World J Gastrointest Surg. 2010;2(7):231–41.
4. Stewart DB Sr, Gaertner W, Glasgow S, Migaly J, Feingold D, Steele SR.Clinical practice guideline for the management of anal ssures. Dis Colon Rectum. 2017;60(1):7–14.
5. Lund JN. Nitric oxide deciency in the internal anal sphinc­ter of patients with chronic anal ssure. Int J Colorectal Dis. 2006;21(7):673–5.
6. Schouten WR, Briel JW, Auwerda JJ.Relationship between anal pressure and anodermal blood ow. The vascular pathogenesis of anal ssures. Dis Colon Rectum. 1994;37(7):664–9.
7. Klosterhalfen B, Vogel P, Rixen H, Mittermayer C.Topography of the inferior rectal artery: a possible cause of chronic, primary anal ssure. Dis Colon Rectum. 1989;32(1):43–52.
8. Lund JN, Binch C, McGrath J, Sparrow RA, Scholeeld JH.Topographical distribution of blood supply to the anal canal. Br J Surg. 1999;86(4):496–8.
9. Corby H, Donnelly VS, O’Herlihy C, O’Connell PR.Anal canal pressures are low in women with postpartum anal ssure. Br J Surg. 1997;84(1):86–8.
10. Nelson R.A systematic review of medical therapy for anal ssure. Dis Colon Rectum. 2004;47(4):422–31.
11. Jensen SL. Maintenance therapy with unprocessed bran in the prevention of acute anal ssure recurrence. J R Soc Med. 1987;80(5):296–8.
12. Sanei B, Mahmoodieh M, Masoudpour H. Comparison of topi­cal glyceryl trinitrate with diltiazem ointment for the treatment of chronic anal ssure: a randomized clinical trial. Acta Chir Belg. 2009;109(6):727–30.
13. Antropoli C, Perrotti P, Rubino M, Martino A, De Stefano G, Migliore G, et al. Nifedipine for local use in conservative treat­ment of anal ssures: preliminary results of a multicenter study. Dis Colon Rectum. 1999;42(8):1011–5.
14. Samim M, Twigt B, Stoker L, Pronk A. Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal s­sure: a double-blind randomized clinical trial. Ann Surg. 2012;255(1):18–22.
15. Brisinda G, Cadeddu F, Brandara F, Marniga G, Vanella S, Nigro C, etal. Botulinum toxin for recurrent anal ssure following lateral internal sphincterotomy. Br J Surg. 2008;95(6):774–8.
16. Berkel AE, Rosman C, Koop R, van Duijvendijk P, van der Palen J, Klaase JM.Isosorbide dinitrate ointment vs botulinum toxin A (Dysport) as the primary treatment for chronic anal ssure: a ran­domized multicentre study. Colorectal Dis. 2014;16(10):O360–6.
17. Chen HL, Woo XB, Wang HS, Lin YJ, Luo HX, Chen YH, etal. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal ssure: a meta-analysis of randomized control trials. Tech Coloproctol. 2014;18(8):693–8.
18. Nelson RL, Thomas K, Morgan J, Jones A.Non surgical therapy for anal ssure. Cochrane Database Syst Rev. 2012;(2):CD003431.
19. Nelson RL, Chattopadhyay A, Brooks W, Platt I, Paavana T, Earl S.Operative procedures for ssure in ano. Cochrane Database Syst Rev. 2011;(11):CD002199.
20. Renzi A, Izzo D, Di Sarno G, Talento P, Torelli F, Izzo G, etal. Clinical, manometric, and ultrasonographic results of pneumatic balloon dilatation vs. lateral internal sphincterotomy for chronic
anal ssure: a prospective, randomized, controlled trial. Dis Colon Rectum. 2008;51(1):121–7.
21. Arroyo A, Perez F, Serrano P, Candela F, Lacueva J, Calpena R.Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal ssure: long-term results of a prospective randomized clinical and manometric study. Am J Surg. 2005;189(4):429–34.
22. Brown CJ, Dubreuil D, Santoro L, Liu M, O’Connor BI, McLeod RS. Lateral internal sphincterotomy is superior to topical nitro­glycerin for healing chronic anal ssure and does not compromise long-term fecal continence: six-year follow-up of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2007;50(4):442–8.
23. Davies I, Dafydd L, Davies L, Beynon J.Long term outcomes after lateral anal sphincterotomy for anal ssure: a retrospective cohort study. Surg Today. 2014;44(6):1032–9.
24. de Rosa M, Cestaro G, Vitiello C, Massa S, Gentile M.Conservative versus surgical treatment for chronic anal idiopathic ssure: a pro­spective randomized trial. Updates Surg. 2013;65(3):197–200.
25. Gandomkar H, Zeinoddini A, Heidari R, Amoli HA.Partial lateral internal sphincterotomy versus combined botulinum toxin A injec­tion and topical diltiazem in the treatment of chronic anal ssure: a randomized clinical trial. Dis Colon Rectum. 2015;58(2):228–34.
26. Iswariah H, Stephens J, Rieger N, Rodda D, Hewett P.Randomized prospective controlled trial of lateral internal sphincterotomy ver­sus injection of botulinum toxin for the treatment of idiopathic s­sure in ano. ANZ J Surg. 2005;75(7):553–5.
27. Katsinelos P, Papaziogas B, Koutelidakis I, Paroutoglou G, Dimiropoulos S, Souparis A, etal. Topical 0.5% nifedipine vs. lat­eral internal sphincterotomy for the treatment of chronic anal s­sure: long-term follow-up. Int J Colorectal Dis. 2006;21(2):179–83.
28. Mentes BB, Irkorucu O, Akin M, Leventoglu S, Tatlicioglu E. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal ssure. Dis Colon Rectum. 2003;46(2):232–7.
29. Nasr M, Ezzat H, Elsebae M.Botulinum toxin injection versus lat­eral internal sphincterotomy in the treatment of chronic anal ssure: a randomized controlled trial. World J Surg. 2010;34(11):2730–4.
30. Richard CS, Gregoire R, Plewes EA, Silverman R, Burul C, Buie D, etal. Internal sphincterotomy is superior to topical nitroglycerin in the treatment of chronic anal ssure: results of a randomized, controlled trial by the Canadian Colorectal Surgical Trials Group. Dis Colon Rectum. 2000;43(8):1048–57; discussion 57–8.
31. Sileri P, Stol VM, Franceschilli L, Grande M, Di Giorgio A, D’Ugo S, et al. Conservative and surgical treatment of chronic anal ssure: prospective longer term results. J Gastrointest Surg. 2010;14(5):773–80.
32. Valizadeh N, Jalaly NY, Hassanzadeh M, Kamani F, Dadvar Z, Azizi S, et al. Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal ssure: ran­domized prospective controlled trial. Langenbecks Arch Surg. 2012;397(7):1093–8.
33. Garcia-Granero E, Sanahuja A, Garcia-Botello SA, Faiz O, Esclapez P, Espi A, etal. The ideal lateral internal sphincterotomy: clinical and endosonographic evaluation following open and closed internal anal sphincterotomy. Colorectal Dis. 2009;11(5):502–7.
34. Littlejohn DR, Newstead GL.Tailored lateral sphincterotomy for anal ssure. Dis Colon Rectum. 1997;40(12):1439–42.
35. Ho KS, Ho YH.Randomized clinical trial comparing oral nifedip­ine with lateral anal sphincterotomy and tailored sphincterotomy in the treatment of chronic anal ssure. Br J Surg. 2005;92(4):403–8.
36. Mentes BB, Ege B, Leventoglu S, Oguz M, Karadag A.Extent of lateral internal sphincterotomy: up to the dentate line or up to the ssure apex? Dis Colon Rectum. 2005;48(2):365–70.
37. Liang J, Church JM.Lateral internal sphincterotomy for surgically recurrent chronic anal ssure. Am J Surg. 2015;210(4):715–9.
38. Giordano P, Gravante G, Grondona P, Ruggiero B, Porrett T, Lunniss PJ. Simple cutaneous advancement ap anoplasty for
12 Anal Fissure andAnal Stenosis
247
resistant chronic anal ssure: a prospective study. World J Surg. 2009;33(5):1058–63.
39. Keneck NJ, Gee AS, Durdey P.Treatment of resistant anal ssure with advancement anoplasty. Colorectal Dis. 2002;4(6):463–6.
40. Magdy A, El Nakeeb A, El Fouda Y, Youssef M, Farid M. Comparative study of conventional lateral internal sphincter­otomy, V-Y anoplasty, and tailored lateral internal sphincterotomy with V-Y anoplasty in the treatment of chronic anal ssure. J Gastrointest Surg. 2012;16(10):1955–62.
41. Pelta AE, Davis KG, Armstrong DN.Subcutaneous ssurotomy: a novel procedure for chronic ssure-in-ano. A review of 109 cases. Dis Colon Rectum. 2007;50(10):1662–7.
42. Mousavi SR, Shari M, Mehdikhah Z.A comparison between the results of ssurectomy and lateral internal sphincterotomy in the surgical management of chronic anal ssure. J Gastrointest Surg. 2009;13(7):1279–82.
43. Engel AF, Eijsbouts QA, Balk AG. Fissurectomy and isosorbide dinitrate for chronic ssure in ano not responding to conservative treatment. Br J Surg. 2002;89(1):79–83.
44. Lindsey I, Cunningham C, Jones OM, Francis C, Mortensen NJ. Fissurectomy-botulinum toxin: a novel sphincter-sparing procedure for medically resistant chronic anal ssure. Dis Colon Rectum. 2004;47(11):1947–52.
45. Ouraghi A, Nieuviarts S, Mougenel JL, Allez M, Barthet M, Carbonnel F, etal. Iniximab therapy for Crohn’s disease anoperi­neal lesions. Gastroenterol Clin Biol. 2001;25(11):949–56.
46. Sweeney JL, Ritchie JK, Nicholls RJ.Anal ssure in Crohn’s dis­ease. Br J Surg. 1988;75(1):56–7.
47. Viamonte M, Dailey TH, Gottesman L.Ulcerative disease of the ano­rectum in the HIV+ patient. Dis Colon Rectum. 1993;36(9):801–5.
48. Shawki S, Costedio M.Anal ssure and stenosis. Gastroenterol Clin North Am. 2013;42(4):729–58.
49. Liberman H, Thorson AG.How I do it. Anal stenosis. Am J Surg. 2000;179(4):325–9.
50. Milsom JW, Mazier WP.Classication and management of postsur­gical anal stenosis. Surg Gynecol Obstet. 1986;163(1):60–4.
51. Khubchandani IT. Anal stenosis. Surg Clin North Am. 1994;74(6):1353–60.
52. Maria G, Alfonsi G, Nigro C, Brisinda G. Whitehead’s hemor­rhoidectomy. A useful surgical procedure in selected cases. Tech Coloproctol. 2001;5(2):93–6.
53. Bonello JC.Who’s afraid of the dentate line? The Whitehead hem­orrhoidectomy. Am J Surg. 1988;156(3 Pt 1):182–6.
54. Brisinda G, Vanella S, Cadeddu F, Marniga G, Mazzeo P, Brandara F, etal. Surgical treatment of anal stenosis. World J Gastroenterol. 2009;15(16):1921–8.
55. Lehmann JP, Johansson HO, Graf W. Long-term functional results after excisional haemorrhoidectomy. Colorectal Dis. 2020;22:824–30.
56. Sagar PM, Pemberton JH. Intraoperative, postoperative and reoperative problems with ileoanal pouches. Br J Surg. 2012;99(4):454–68.
57. Kumar A, Daga R, Vijayaragavan P, Prakash A, Singh RK, Behari A, etal. Anterior resection for rectal carcinoma- risk fac­tors for anastomotic leaks and strictures. World J Gastroenterol. 2011;17(11):1475–9.
58. Couto RA, Zequeira JJ, Vicente HL.Recalcitrant coloanal strictures in children managed by transanal circular stapled reanastomosis. J Pediatr Surg. 2014;49(11):1686–8.
59. Halleran DR, Sanchez AV, Rentea RM, Ahmad H, Weaver L, Reck C, et al. Assessment of the Heineke-Mikulicz anoplasty for skin level postoperative anal strictures and congenital anal stenosis. J Pediatr Surg. 2019;54(1):118–22.
60. Ravo B, Amato A, Bianco V, Boccasanta P, Bottini C, Carriero A, etal. Complications after stapled hemorrhoidectomy: can they be prevented? Tech Coloproctol. 2002;6(2):83–8.
61. Bouchard D, Abramowitz L, Bouguen G, Brochard C, Dabadie A, de Parades V, et al. Anoperineal lesions in Crohn’s disease: French recommendations for clinical practice. Tech Coloproctol. 2017;21(9):683–91.
62. Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ.Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg. 2005;241(5):796–801; discussion -2.
63. Katdare MV, Ricciardi R. Anal stenosis. Surg Clin North Am. 2010;90(1):137–45, Table of Contents.
64. Crapp AR, Alexander-Williams J. Fissure-in-ano and anal ste­nosis. Part I: conservative management. Clin Gastroenterol. 1975;4(3):619–28.
65. Jenetzky E, Reckin S, Schmiedeke E, Schmidt D, Schwarzer N, Grasshoff-Derr S, et al. Practice of dilatation after surgi­cal correction in anorectal malformations. Pediatr Surg Int. 2012;28(11):1095–9.
66. Linares L, Moreira LF, Andrews H, Allan RN, Alexander-Williams J, Keighley MR. Natural history and treatment of anorectal strictures complicating Crohn’s disease. Br J Surg. 1988;75(7): 653–5.
67. Michelassi F, Melis M, Rubin M, Hurst RD. Surgical treat­ment of anorectal complications in Crohn’s disease. Surgery. 2000;128(4):597–603.
68. MacDonald A, Smith A, McNeill AD, Finlay IG.Manual dilatation of the anus. Br J Surg. 1992;79(12):1381–2.
69. Duieb Z, Appu S, Hung K, Nguyen H.Anal stenosis: use of an algorithm to provide a tension-free anoplasty. ANZ J Surg. 2010;80(5):337–40.
70. Khubchandani IT. Mucosal advancement anoplasty. Dis Colon Rectum. 1985;28(3):194–6.
71. Nickell WB, Woodward ER. Advancement aps for treatment of anal stricture. Arch Surg. 1972;104(2):223–4.
72. Casadesus D, Villasana LE, Diaz H, Chavez M, Sanchez IM, Martinez PP, etal. Treatment of anal stenosis: a 5-year review. ANZ J Surg. 2007;77(7):557–9.
73. Martin EG.The plastic use of skin in simple anal stricture, recon­struction of anal lining, pilonidal disease. Tr Am Proct Soc. 1944;44:195–200.
74. Rakhmanine M, Rosen L, Khubchandani I, Stasik J, Riether RD.Lateral mucosal advancement anoplasty for anal stricture. Br J Surg. 2002;89(11):1423–4.
75. Aitola PT, Hiltunen KM, Matikainen MJ.Y-V anoplasty combined with internal sphincterotomy for stenosis of the anal canal. Eur J Surg. 1997;163(11):839–42.
76. Angelchik PD, Harms BA, Starling JR.Repair of anal stricture and mucosal ectropion with Y-V or pedicle ap anoplasty. Am J Surg. 1993;166(1):55–9.
77. Gingold BS, Arvanitis M.Y-V anoplasty for treatment of anal stric­ture. Surg Gynecol Obstet. 1986;162(3):241–2.
78. Maria G, Brisinda G, Civello IM.Anoplasty for the treatment of anal stenosis. Am J Surg. 1998;175(2):158–60.
79. Borsuk DJ, Melich G, Sugrue J, Calata J, Seitz IA, Park JJ, et al. Wide local excision of perianal Paget’s disease with gluteal ap reconstruction: an interdisciplinary approach. J Vis Surg. 2016;2:159.
80. Rosen L.Anoplasty. Surg Clin North Am. 1988;68(6):1441–6.
81. Caplin DA, Kodner IJ.Repair of anal stricture and mucosal ectro­pion by simple ap procedures. Dis Colon Rectum. 1986;29(2): 92–4.
82. Christensen MA, Pitsch RM Jr, Cali RL, Blatchford GJ, Thorson AG. “House” advancement pedicle ap for anal stenosis. Dis Colon Rectum. 1992;35(2):201–3.
83. Farid M, Youssef M, El Nakeeb A, Fikry A, El Awady S, Morshed M. Comparative study of the house advancement ap, rhomboid ap, and y-v anoplasty in treatment of anal stenosis: a prospective randomized study. Dis Colon Rectum. 2010;53(5):790–7.
248
V. L. Tsikitis and S. Marecik
84. Sentovich SM, Falk PM, Christensen MA, Thorson AG, Blatchford GJ, Pitsch RM.Operative results of House advancement anoplasty. Br J Surg. 1996;83(9):1242–4.
85. Alver O, Ersoy YE, Aydemir I, Erguney S, Teksoz S, Apaydin B, etal. Use of “house” advancement ap in anorectal diseases. World J Surg. 2008;32(10):2281–6.
86. Pearl RK, Hooks VH 3rd, Abcarian H, Orsay CP, Nelson RL.Island ap anoplasty for the treatment of anal stricture and mucosal ectro­pion. Dis Colon Rectum. 1990;33(7):581–3.
87. Handaya Y, Sunardi M. Bilateral rotational S ap technique for preventing restenosis in patients with severe circular anal
stenosis: a review of 2 cases. Ann Coloproctol. 2019;35: 221–4.
88. Koscinski T.Treatment of iatrogenic anal stricture. Pol Przegl Chir. 2007;79(4):280–5.
89. Orkin BA.Perineal reconstruction with local aps: technique and results. Tech Coloproctol. 2013;17(6):663–70.
90. Brochard C, Siproudhis L, Wallenhorst T, Cuen D, d’Halluin PN, Garros A, etal. Anorectal stricture in 102 patients with Crohn’s disease: natural history in the era of biologics. Aliment Pharmacol Ther. 2014;40(7):796–803.
Cryptoglandular Abscess andFistula
EricK.Johnson andGretaBernier
13
Key Concepts
• Anorectal abscess should be treated with surgical drain­age, not antibiotic therapy.
• At least one-third of cryptoglandular abscesses will prog­ress to stula.
• Anal stula in the typical patient should be evaluated with examination under anesthesia. Subsequent management will be dictated by anatomic ndings in the operating room.
• Priorities of management are control of sepsis, mainte­nance of continence, and cure without recurrence, gener­ally in that order.
• While there are many new and emerging methods of treat­ment, the surgeon should be critical of the published lit­erature and base their informed consent discussion on their observed results over time. Most studies would indi­cate that at least 12months of follow-up is required to determine success.

Introduction

Anorectal abscess and stula-in-ano are commonly encoun­tered in a colorectal surgery clinic. It is imperative for the surgeon to fully understand the pathophysiology of this dis­ease process, the anatomy of the anal canal and pelvis with respect to cryptoglandular abscess and stula, and how to appropriately individualize care for each patient.
As stated by Dr. Herand Abcarian, “It is difcult if not
impossible to accurately assess the incidence of anorectal abscesses because they often drain spontaneously or are
incised and drained in a physician’s ofce, emergency room or surgicenter” [1]. Similarly, our estimates do not account for those treated with antibiotics alone in the primary care setting. This is further complicated by the misdiagnosis of many common anorectal pathologies as “hemorrhoids,” both by patients and referring physicians.
The incidence of anorectal abscess is documented as 8.6– 20 patients per 100,000 people, with males being more affected than females at an incidence of 2.4–3:1 and presen­tation at a mean age of 40years [24]. The most common etiology is cryptoglandular, accounting for 90% of anorectal abscesses, although both abscess and stula can arise from a multitude of etiologies, including Crohn’s disease, obstetric injury, ssure, and infectious etiologies such as tuberculosis, sarcoid, and HIV.These etiologies are outside the scope of this chapter but will be discussed in further detail in subse­quent chapters.

Cryptoglandular Pathophysiology

Cryptoglandular abscess and stula-in-ano arise from glands at the dentate line, nestled between the anal papilla and the columns of Morgagni. These glands extend into the submu­cosal space, internal sphincter, intersphincteric space, and external sphincter to varying degrees. When bacteria and debris become inspissated in these glands, an infection develops, and this will track along the course of the gland or follow to the path of least resistance from its origin (Fig.13.1) [5, 6]. This theory was described and popularized by Eisenhammer in the 1950s [5].
E. K. Johnson (*) Department of Colon and Rectal Surgery, Cleveland Clinic, Cleveland, OH, USA
G. Bernier UW Medicine– Valley Medical Center, Department of Surgery, Renton, WA, USA
© Springer Nature Switzerland AG 2022 S. R. Steele et al. (eds.), The ASCRS Textbook of Colon and Rectal Surgery, https://doi.org/10.1007/978-3-030-66049-9_13
Cryptoglandular Abscess
As described above, anorectal abscesses occur in multiple spaces in the pelvis and are so classied by these locations: perianal, ischiorectal, intersphincteric, and supralevator
249
250
E. K. Johnson and G. Bernier
toms such as a ssure, thrombosed hemorrhoid, sexually transmitted infection, or malignancy. Supralevator abscesses may arise from cephalad extension of a cryptoglandular ori­gin but, however, are more commonly associated with an intraabdominal process such as diverticular disease, malig­nancy, or Crohn’s disease. Perianal and ischiorectal abscesses represent the majority of anorectal abscess, 65–80% [7, 8]. Ramanujam et al. further described the incidence of each subtype of anorectal abscess in their evaluation of 1023 patients presenting over a 5.5-year period. In their series, perianal abscesses accounted for 42.7% of anorectal abscesses, ischiorectal for 22.7%, intersphincteric for 21.4%, and supralevator for 7.3%.

Diagnosis

Fig. 13.1 Image depicting the anal canal with surrounding muscula-
ture and crypt glands in cross section coursing through the internal anal sphincter. (Reprinted with permission, The Cleveland Clinic Center for Medical Art & Photography © 2009–2020. All Rights Reserved)
Fig. 13.2 Cross-sectional image showing abscess formation in the dif­ferent potential spaces. (Reprinted with permission, The Cleveland Clinic Center for Medical Art & Photography © 2009–2020. All Rights Reserved)
(Fig. 13.2). Another classication, horseshoe abscess, describes an abscess that courses posteriorly through the deep postanal space to involve the bilateral ischiorectal spaces.
Both perianal abscesses and ischiorectal abscesses typi­cally present with perianal pain, swelling, and uctuance, with possible spontaneous drainage of purulent uid. Intersphincteric abscesses typically do not have any external manifestations but rather present as intense anal pain, such that the patient will often not tolerate a digital rectal exam, without any other clear pathology to account for these symp-
History and physical examination are generally sufcient to diagnose perianal and ischiorectal abscesses. Imaging adjuncts, such as CT scan, MRI, stulogram, and endoanal ultrasound, are not indicated for the patient with classic uncomplicated presentation, without diagnostic dilemma or comorbidity, and a uctuant area is appreciated on examina­tion [3, 9]. Imaging may be benecial in the workup of those with an unclear diagnosis, such as those with isolated inter­sphincteric abscess or those that have other complicating factors, such as history of malignancy, radiation, Crohn’s disease, prior anorectal operations, or trauma, or those with concern for complex abscesses such as horseshoe or supral­evator extension. Imaging adjuncts may also be useful in select cases for management of associated stula-in-ano, as discussed later in this chapter.

Treatment

The primary treatment for anorectal abscess is expeditious incision and drainage. Perianal and ischiorectal abscesses should be drained through the skin overlying the area of uctuance. If the abscess cavity is large, the incision should be made over the area of the cavity that is closest to the anal verge. With this technique, if the patient develops a resul­tant stula-in-ano, the tract will not be unnecessarily long. This consideration is important, as approximately one-third of acute anorectal abscesses persist as a stula-in-ano [8,
10, 11].
Intersphincteric abscesses and supralevator abscesses require special considerations both for effective drainage and to avoid iatrogenic injury. Intersphincteric abscesses typi­cally require internal drainage at the dentate line via sphinc­terotomy if there is no external area of uctuance.
The route of drainage is of particular importance for supralevator abscesses. Those that arise from an intraabdom-
Inter
Submucosal space
ic space
13 Cryptoglandular Abscess andFistula
Fig. 13.3 Image showing different potential spaces for abscess formation, with emphasis on appropriate drainage route for supralevator abscess. (Reprinted with permission, The Cleveland Clinic Center for Medical Art & Photography © 2009–2020. All Rights Reserved)
251
Ischiorectal space
External sphincter
nal sphincter
Perianal space
inal source should be drained either transabdominally using interventional radiology assistance or transrectally, while those arising from cephalad extension of a cryptoglandular source via the intersphincteric space should be drained tran­srectally. Those that arise from a cephalad extension of an ischiorectal abscess should be drained transcutaneously. These principles are important in order to avoid iatrogenic creation of a suprasphincteric stula (Fig.13.3).
Another special case is drainage of the horseshoe abscess. As stated previously, these typically arise from extension of an ischiorectal abscess via the deep postanal space. In order to adequately drain these abscesses, there must be both bilat­eral transcutaneous ischiorectal drainage and posterior drain­age via division of the anococcygeal ligament to access the deep postanal space. Other examples of a horseshoe abscess include those arising from a perianal abscess extending through the supercial postanal space, those extending through the anterior perianal space, or a supralevator abscesses coursing through the posterior supralevator space (Fig.13.4).

Acute Fistula Management

By denition, 100% of anorectal abscesses of cryptoglandu­lar etiology will have a path from the dentate line to the drained abscess cavity. At the time of acute abscess presenta­tion, 30–70% of patients will have an identiable tract [8,
1214]; however, this tract is not mature and will only
become a stula tract in ~30–35% of patients. There is also a
Supralevator space
Intrasphincter
risk of creating a false passage while attempting to identify a stula tract in the setting of acute inammation. If a tract is identied, some advocate for primary stulotomy at the time of abscess drainage to reduce recurrent abscess or need for second operation were a stula to develop. And while some have shown a decrease in both abscess recurrence and stula formation with primary stulotomy [12], this approach results in occasionally unnecessary sphincter division in patients who would not have ultimately developed a chronic stula. In addition, inammation from the concomitant abscess will make it more difcult to discern the degree of muscle involvement, precluding appropriate surgical judg­ment, thereby potentially increasing the risk of incontinence [12, 15]. Given this controversy and potential risks, it is not generally recommended to denitively manage this tract at the time of abscess drainage.
Incision and drainage in the clinic instead of the operating room is preferred as it expedites the time to control of sepsis. In order to perform this procedure in clinic, the provider must have an adequate setup with anesthetic, instruments, patient positioning, and an amenable patient. In many cases, patients will tolerate in ofce drainage. This can be facili­tated by injecting a wheal of anesthetic at the intended site of drainage, decompressing the cavity through the wheal with a larger needle prior to injecting additional anesthetic, and then completing drainage via a small incision. Complex peri­anal abscesses, such as those that are deep/nonpalpable, those that are associated with tissue necrosis, and those inpa­tients who are intolerant of a bedside procedure, are better managed in the operating room.